Cable Grippers
    23.
    发明授权
    Cable Grippers 有权
    电缆夹爪

    公开(公告)号:US08608144B2

    公开(公告)日:2013-12-17

    申请号:US11995951

    申请日:2007-01-09

    IPC分类号: B25B1/24

    CPC分类号: B63B35/06 B63B21/08 B63B21/66

    摘要: An assembly of a cable gripper and a cable that has an outer protective layer formed from plastically deformable material, over an inner tensile strength portion). The cable gripper includes at least one gripper member having a supported outer end and an active inner end penetrating the outer protective layer and gripping the inner tensile strength portion beneath the outer protective layer. The active inner end includes a material of sufficient hardness to penetrate the outer protective layer by movement of the gripper member through the outer layer from an inoperative to an operative position.

    摘要翻译: 电缆夹具和电缆的组件,其具有由可塑性变形材料形成的外部保护层,在内部抗拉强度部分上)。 电缆夹持器包括至少一个夹持构件,其具有支撑的外端和穿过外保护层的主动内端,并且夹持外保护层下方的内拉伸强度部分。 主动内端包括足够硬度的材料,通过夹持构件通过外层从不起作用到操作位置的移动而穿透外保护层。

    Modular Case Goods and Components
    25.
    发明申请
    Modular Case Goods and Components 审中-公开
    模块化商品和组件

    公开(公告)号:US20110115351A1

    公开(公告)日:2011-05-19

    申请号:US12915493

    申请日:2010-10-29

    IPC分类号: A47B96/16 A47B91/16 B23Q3/00

    摘要: The present disclosure provides modular case good apparatus including a base unit having a shell including a back panel with a lower edge, two side panels each with a rear edge, each side panel joined to the back panel on opposite ends of said back panel, a front panel joined to the one or more sides opposite the back panel, a top surface and a bottom surface, wherein said back panel does not extend to the surface upon which said base unit is placed, and one or more alignment dowel receiving elements; a chase including: a front panel which does not extend to the surface upon which the base unit is placed, two side panels, each having a front edge which do not extend to the surface upon which the base unit is placed, at least one alignment dowel receiving element and a top panel, wherein said base unit and said chase unit are reversibly connected through inserting the alignment dowel into the alignment dowel receiving elements on the back panel of the base unit and one or more alignment dowel receiving elements on the front panel of the chase and the insertion of one or more fastener assemblies through the front panel of the chase and the back panel of the base unit.

    摘要翻译: 本公开提供了一种模块化壳体良好装置,包括具有壳体的基座单元,壳体包括具有下边缘的后面板,每个具有后边缘的两个侧板,每个侧板连接到所述后面板的相对端上的后面板, 前面板连接到与后面板相对的一个或多个侧面,顶面和底面,其中所述后面板不延伸到所述基座单元所在的表面,以及一个或多个定位销钉接收元件; 追逐包括:未延伸到放置基座单元的表面的前面板,两个侧板,每个具有不延伸到放置基座单元的表面的前边缘,至少一个对准 定位销接收元件和顶板,其中所述基座单元和所述追逐单元通过将所述对准定位销插入到所述基座单元的后面板上的对准定位销接收元件中而被可逆地连接,并且所述前板上的一个或多个定位销钉接收元件 的一个或多个紧固件组件穿过追逐的前面板和基座单元的后面板插入。

    COFFEE WITH ENHANCED FLAVOR PROVIDED BY 3,7-DIMETHYLOCTA-1,6-DIEN-3-OL
    26.
    发明申请
    COFFEE WITH ENHANCED FLAVOR PROVIDED BY 3,7-DIMETHYLOCTA-1,6-DIEN-3-OL 审中-公开
    由3,7-二甲基-1,6-二烯-3-OL提供的具有增强香味的咖啡

    公开(公告)号:US20110076365A1

    公开(公告)日:2011-03-31

    申请号:US12963162

    申请日:2010-12-08

    IPC分类号: A23F5/46 A23F5/02

    摘要: A coffee product and process are provided which produce a coffee product having elevated levels of 3,7-dimethylocta-1,6-dien-3-ol. In various forms, the coffee product is dry roast and ground coffee or a dry soluble coffee product such as a powder or granule form. The process includes adding 3,7-dimethylocta-1,6-dien-3-ol to roast and ground coffee or a soluble coffee to produce an enhanced coffee flavor beverage, or to an extract or solution thereof.

    摘要翻译: 提供了一种咖啡产品和方法,其产生具有升高水平的3,7-二甲基辛-1,6-二烯-3-醇的咖啡产品。 以各种形式,咖啡产品是干烤和研磨咖啡或干燥可溶性咖啡产品,例如粉末或颗粒形式。 该方法包括向焙炒和研磨的咖啡或可溶性咖啡中加入3,7-二甲基辛-1,6-二烯-3-醇以产生增强的咖啡香料饮料,或其提取物或溶液。

    PYRIMIDINE DERIVATIVES
    27.
    发明申请

    公开(公告)号:US20100267755A1

    公开(公告)日:2010-10-21

    申请号:US10477546

    申请日:2002-05-23

    摘要: The invention provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R1 and R2 are independently selected from the group consisting of H, C1-6alkyl, C1-2alkyl substituted by one to five fluorine atoms, C3-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl, C4-12bridged cycloalkyl, A(CR7R8)n and B(CR7R8)n; R3 is selected from the group consisting of C1-6alkyl, NH2 and R10CONH; R4 is C1-2alkyl substituted by one to five fluorine atoms; R5 is selected from the group consisting of H, C1-4alkyl, C1-2alkyl substituted with one to five fluorine atoms, halogen and C3-10cycloalkylC0-6alkyl, with the proviso that when R6 is H R5 is not H. R6 is selected from the group consisting of H, C1-4alkyl, C1-2alkyl substituted with one to five fluorine atoms, halogen, C1-4alkoxy, CN, NO2, C1-6alkylOCO, NH2CO, C1-6alkylNHCO, NH2, C1-6alkylNH, (C1-6alkyl)2N, (C1-6alkyl)2NCO, C1-6alkylCONH, NH2SO2, C1-6alkylNHSO2, (C1-6alkyl)2NSO2, C1-6alkylSO2NH, ArSO2NH, C1-6alkylSO2, ArSO2, C3-10cycloalkylC0-6alkyl, C3-6alkenyl and C3-6alkynyl, with the proviso that when R5 is H R6 is not H. R7 and R8 are independently selected from H or C1-6alkyl; A is an unsubstituted 5- or 6-membered heteroaryl or an unsubstituted 6-membered aryl, or a 5- or 6-membered heteroaryl or a 6-membered aryl substituted by one or more R9; R9 is selected from the group consisting of hydroxy, halogen, C1-6alkyl, C1-6alkyl substituted by one more fluorine atoms, C1-6alkoxy, C1-6alkoxy substituted by one or more F, NH2SO2 and C1-6alkylSO2; R10 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl; B is selected from the group consisting of defines the point of attachment of the ring; and n is 0 to 4. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever and inflammation of a variety of conditions and diseases.

    CONCENTRATION OF PARTICLES IN A FLUID WITHIN AN ACOUSTIC STANDING WAVE FIELD
    29.
    发明申请
    CONCENTRATION OF PARTICLES IN A FLUID WITHIN AN ACOUSTIC STANDING WAVE FIELD 审中-公开
    在声学波形场中流体中的颗粒浓度

    公开(公告)号:US20090101547A1

    公开(公告)日:2009-04-23

    申请号:US11532297

    申请日:2006-09-15

    IPC分类号: B01D43/00 B01J19/10

    摘要: A device for performing the manipulation of particles suspended in a fluid is disclosed. The device comprises a duct for the flow of a fluid in which particles are suspended, an acoustic transducer, and a reflector for establishing an acoustic standing wave field across the width of the duct. It has been unexpectedly found that optimum performance of the device occurs when the spacing between the transducer and a reflector is 300 microns or less. The device seeks to overcome prior engineering difficulties that prevented one from observing the individual particle bands or separating the individual particle bands from the duct.

    摘要翻译: 公开了一种用于执行悬浮在流体中的颗粒操作的装置。 该装置包括用于流动其中颗粒悬浮的流体的管道,声换能器和用于在管道的宽度上建立声驻波的反射器。 意外地发现,当换能器和反射器之间的间距为300微米或更小时,会发生器件的最佳性能。 该设备试图克服以前的工程困难,防止人们观察到各个颗粒带或将各个颗粒带与管道分开。

    17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
    30.
    发明授权
    17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents 失效
    17β-硫代硫酸钠17α-芳基羰氧基氧基雄甾烷衍生物作为抗炎剂

    公开(公告)号:US07498321B2

    公开(公告)日:2009-03-03

    申请号:US10343842

    申请日:2001-08-03

    CPC分类号: C07J31/006

    摘要: There are provided according to the invention compounds of formula (I) wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents —C(═O)-aryl or —C(═O)-heteroaryl; R3 represents hydrogen, methyl (which may be in either the α or β configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and——represents a single or a double bond; and salts and solvates thereof. There are also provided processes for preparing compounds of formula (I) and use of the compounds in therapy especially in the treatment of inflammatory and allergic conditions.

    摘要翻译: 根据本发明提供式(I)化合物,其中R 1表示C 1-6烷基或C 1-6卤代烷基; R 2表示-C( - ) - 芳基或-C(-O) - 杂芳基; R3表示氢,甲基(其可以是α或β构型)或亚甲基; R4和R5相同或不同,各自表示氢或卤素; 和 - 表示单键或双键; 及其盐和溶剂合物。 还提供了制备式(I)化合物的方法和该化合物在治疗中的用途,特别是用于治疗炎性和过敏性疾病。